Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|February 24, 2012
Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2Kirsten Mease, Rucha Sane, Lalitha Podila, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 12, 2005
Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activityMitchell E Taub, Lalitha Podila, Diane Ely, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 17, 2021
Case Study 4: Application of Basic Enzyme Kinetics to Metabolism Studies-Real-Life ExamplesYongmei Li, Michelle McCabe, Lalitha Podila, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2014
Case study 3. Application of basic enzyme kinetics to metabolism studies: real-life examplesYongmei Li, Michelle McCabe, Lalitha Podila, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2014
Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in hepatitis C virus patientsRucha S Sane, Gerhard G Steinmann, Qihong Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2013
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteriaJoe Bentz, Michael P O'Connor, Dallas Bednarczyk, et al.
Pageof 1